Analysis of tanshinone IIA induced cellular apoptosis in leukemia cells by genome-wide expression profiling by Chang Liu et al.
RESEARCH ARTICLE Open Access
Analysis of tanshinone IIA induced cellular
apoptosis in leukemia cells by genome-wide
expression profiling
Chang Liu1*†, Jianqin Li1†, Liangjie Wang4†, Fuqun Wu2, Linfang Huang1, Yue Xu2,3, Jieyu Ye2, Bin Xiao2,3,
Fanyi Meng2, Shilin Chen1 and Mo Yang2,4*
Abstract
Background: Tanshinone IIA (Tan IIA) is a diterpene quinone extracted from the root of Salvia miltiorrhiza, a
Chinese traditional herb. Although previous studies have reported the anti-tumor effects of Tan IIA on various
human cancer cells, the underlying mechanisms are not clear. The current study was undertaken to investigate the
molecular mechanisms of Tan IIA’s apoptotic effects on leukemia cells in vitro.
Methods: The cytotoxicity of Tan IIA on different types of leukemia cell lines was evaluated by the 3-[4,5-
dimethylthiazol-2,5]-diphenyl tetrazolium bromide (MTT) assay on cells treated without or with Tan IIA at different
concentrations for different time periods. Cellular apoptosis progression with and without Tan IIA treatment was
analyzed by Annexin V and Caspase 3 assays. Gene expression profiling was used to identify the genes regulated
after Tan IIA treatment and those differentially expressed among the five cell lines. Confirmation of these
expression regulations was carried out using real-time quantitative PCR and ELISA. The antagonizing effect of a PXR
inhibitor L-SFN on Tan IIA treatment was tested using Colony Forming Unit Assay.
Results: Our results revealed that Tan IIA had different cytotoxic activities on five types of leukemia cells, with the
highest toxicity on U-937 cells. Tan IIA inhibited the growth of U-937 cells in a time- and dose-dependent manner.
Annexin V and Caspase-3 assays showed that Tan IIA induced apoptosis in U-937 cells. Using gene expression
profiling, 366 genes were found to be significantly regulated after Tan IIA treatment and differentially expressed
among the five cell lines. Among these genes, CCL2 was highly expressed in untreated U-937 cells and down-
regulated significantly after Tan IIA treatment in a dose-dependent manner. RT-qPCR analyses validated the
expression regulation of 80% of genes. Addition of L- sulforaphane (L-SFN), an inhibitor of Pregnane × receptor
(PXR) significantly attenuated Tan IIA’s effects using colony forming assays.
Conclusions: Tan IIA has significant growth inhibition effects on U-937 cells through the induction of apoptosis.
And Tan IIA-induced apoptosis might result from the activation of PXR, which suppresses the activity of NF-B and
lead to the down-regulation of CCL2 expression.
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Background
Leukemia is one of the common malignant diseases.
Artificial ionizing radiation, viruses, benzene, some
petro-chemicals, and alkylating chemotherapy agents are
now recognized as major causes of leukemia [1].
Approximately 80-100 million children and adults
around the world develop some forms of leukemia each
year. Identification of anti-leukemia therapies remains a
top research priority. Recently, traditional Chinese her-
bal medicines have gained wide attention as alternative
clinical options for the treatment of various malignant
diseases, including leukemia, due to their antiviral, anti-
oxidant, anti-inflammatory, and tumor apoptosis-indu-
cing properties [2,3]. We are interested in the
characterization of chemical compounds from these her-
bal medicines for further development.
Tanshinone IIA (Tan IIA) is a diterpene quinone
extracted from the root of Salvia miltiorrhiza Bunge.
The growth-inhibitory and apoptosis-inducing effects of
Tan IIA on leukemia cells have recently been reported.
For example, Tan IIA induced apoptosis in human leu-
kemia cell lines HL-60 and K562 through the activation
of caspase-3 [4]. Liu reported that the disruption of
Δψm, activation of caspase-3, down-regulation of Bcl-2,
survivin, and up-regulation of Bax were mainly responsi-
ble for Tan IIA-induced apoptosis on THP-1 cells [5]. In
acute promyelocytic leukemia cells NB4, Tan IIA could
promote cell differentiation and apoptosis with elevated
C/EBP b and CHOP [6].
Tan IIA toxicities on other cancer lines have also been
reported. Tan IIA could inhibit the growth of human
hepatocellular carcinoma cells SMMC-7211 by apoptosis
induction as a result of the up-regulation of P53, Fas
and Bax, and the down-regulation of c-Myc and Bcl-2
[7]. Su suggested that the Tan IIA-induced apoptosis of
breast cancer cells MDA-MB-231 may be attributed to
the increased Bax to Bcl-xL expression ratios [8]. Lu
reported that Tan IIA induced apoptosis in human
breast cancer lines MCF-7 and MDA-MB-231 by
decreasing the expression of P53 and Bcl-2 [9]. In HeLa
cells, Tan IIA led cancer cells to G2/M phase arrest and
subsequent apoptosis by disturbing the microtubule
assembly [10,11]. In lung cancer A549 cells, Tan IIA-
induced apoptosis was associated with a higher ratio of
Bax/Bcl-2 [12].
The above studies have proposed different mechan-
isms of Tan IIA-induced apoptosis. The inconsistency in
these proposed mechanisms may have resulted from the
genetic diversities among the cell systems under study
and the fact that the above studies focused on particular
sets of genes or aspects. In the current paper, instead of
focusing on a few candidate genes, we employed gen-
ome-wide expression profiling to identify the genes that
are differentially expressed among leukemia cell lines
exhibiting various Tan IIA sensitivities and significantly
regulated after Tan IIA treatment as a way to elucidate
the molecular mechanisms of Tan IIA in a systematic
manner.
Methods
Reagents and cell culture conditions
The cell lines used in the current study include HL-60
(Human promyelocytic leukemia), U-937 (Human leuke-
mic monocyte lymphoma), THP-1 (Human acute mono-
cytic leukemia), MEG-01 (megakaryoblastic leukemia)
and MOLT-4 (Human acute lymphoblastic leukemia).
They were purchased from American Type Culture Col-
lection (ATCC, Manassas, VA, USA) and cultured
according to the manufacturer’s instructions. Tan IIA
(National Institute for the Control of Pharmaceutical
and Biological Products, P.R.China) was dissolved in
DMSO solution (0.01%). The stock concentration of
Tan IIA was 200 μg/mL. L-sulforaphane (L-SFN) was
purchased from Sigma-Aldrich (Shanghai, China) Trad-
ing Co., Ltd.
Cytotoxicity assay for various cancer cell lines
Cell viability was evaluated by the 3-[4, 5-dimethylthia-
zol-2, 5]-diphenyl tetrazolium bromide (MTT) assay in
triplicate [13]. For the experiments comparing the five
cell lines, each cell line (2.5 × 105 cells/well) was cul-
tured in the recommended medium in 96-well plates for
24 h. The culture medium was then removed, and the
cells were treated with 0.1% DMSO as vehicle control or
Tan IIA at 30 μg/mL. At the end of the cultivation, 20
μl of MTT working solution was added to the wells,
which were incubated for an additional 4 h at 37°C.
Finally, the absorbance of each well was measured using
a micro-titer plate reader (TECAN, Vienna, Austria) at
570 nm. For the dose- and time-dependent experiments,
the U-937 cells were treated with Tan IIA at concentra-
tions of 1, 2, 3, 5 and 10 μg/mL for 0, 12, 24, 36 and 48
h, respectively.
Detection of Tan IIA-induced apoptosis in U-937 cells
using Annexin V and Caspase-3 assays
The assays were performed as described previously [14].
Briefly, the U-937 cells were maintained in DMEM med-
ium plus 10% fetal bovine serum. Tan IIA (3 μg/mL)
was added and the cells were cultured for 12, 24, 36 and
48 h, respectively. The vehicle control groups were trea-
ted with 0.1% DMSO. Apoptotic cell death was exam-
ined using annexin V-FITC/PI and active caspase-3-PE
reagent kits (BD Biosciences, San Diego, CA, USA)
according to the manufacturer’s instructions. Ten thou-
sand events were acquired for each sample and analyzed
Liu et al. BMC Complementary and Alternative Medicine 2012, 12:5
http://www.biomedcentral.com/1472-6882/12/5
Page 2 of 10
by flow cytometry using Lysis II software (FACScan; BD
Pharmingen).
GeneChip® hybridization
To determine the expression levels of genome-wide
gene transcripts in Tan IIA-treated and control cells,
RNA was extracted using RNA extraction kit (Ambion,
TX) according to manufacturer’s instructions. Five μg of
high-quality total RNA per sample was first converted
to double-stranded cDNA. Biotin-labelled cRNA was
subsequently synthesized on cDNA templates and frag-
mented prior to hybridization to Affymetrix GeneChip
HG-U133 plus 2 slides following the manufacturer’s
recommendations (Affymetrix, Santa Clara, CA, USA).
The integrity of cDNA, cRNA, and fragmented cRNA
was assessed by running aliquots on the Bioanalyzer
(Agilent Technologies Inc., Palo Alto, CA, USA). Hybri-
dized probes were detected with streptavidin-phycoery-
thrin and scanned on an Affymetrix GeneChip Scanner
3000 (Affymetrix, Santa Clara, CA, USA).
Microarray data analysis
Microarray images were visually inspected for hybridiza-
tion artifacts and then analyzed with Affymetrix Gene-
Chip Operating Software (GCOS) according to
Affymetrix’s guidelines (http://www.affymetrix.com).
Affymetrix Microarray Suite MAS 5.0 algorithm was
used for intensity estimation and data normalization.
The cell intensity files (.cel) of all arrays were also ana-
lyzed using dChip software [15], which employs the
invariant set normalization method to normalize the
arrays. In addition, the PM-only model was used to
detect the less-abundant genes in a more sensitive fash-
ion [16,17]. Functional annotation of genes was per-
formed at the NETAFFX Analysis Center. MAPPFinder
[18] was used to find all pathway maps containing the
significantly differentially expressed genes (SDEGs). The
GeneChip data have been submitted to NCBI’s Gene
Expression Omnibus with accession number GSE33358.
Real-time quantitative Polymerase Chain Reaction (RT-
qPCR)
U-937 cells were treated with Tan IIA at 3 μg/mL and
cultured for 1, 2, 4, 6, 12, 24 and 36 h. Total cellular
RNA was extracted using Trizol reagent (Invitrogen
Corp., Carlsbad, CA, USA). The cDNAs were synthe-
sized using M-MLV reverse transcriptase with oligo-d
(T) 15 primers according to the manufacturer’s instruc-
tions (Promega, Madison, WI, USA). The primers used
to detect the expression of target genes are listed in
Additional file 1, Table S1. ABL was used as internal
control. RT-qPCR was performed with SYBR-Green I
intercalating dye (Bio-Rad, Hercules, CA, USA) using a
MyiQ Single Color Real-time PCR Detection System
(Bio-Rad). The following PCR program was used: an
initial denaturation at 95°C for 5 min, 40 cycles of 95°C
for 15 s, 60°C for 15 s and 72°C for 20 s. The RT-qPCR
data were analyzed using the MyiQ software (Bio-Rad).
All experiments were independently repeated three
times.
Enzyme-linked immunosorbent assay (ELISA)
U-937 cells were treated with Tan IIA at different con-
centrations of 0, 1, 3, 6 and 18 μg/mL for 12 h and har-
vested for ELISA. The expression level of CCL2 was
determined using an ELISA kit (R & D, Minneapolis,
MN, USA) following the manufacturer’s instructions. A
monoclonal antibody specific for CCL2 was pre-coated
onto a microplate. Standards and samples were added to
the wells. After washing away the unbound substances,
enzyme-linked polyclonal antibodies specific for CCL2
were added to the wells. Subsequently, substrates were
added. The colors developed were in proportion to the
amount of CCL2 bound on the wells. The optical den-
sity of each well was measured using a microreader
(DNATECH MR 5000) at a wavelength of 450 nm.
U-937 Colony-Forming Unit (CFU) Assay
The assay was performed as described previously [14].
Colony-forming unit-U937 were cultured in methylcel-
lulose (1%) supplemented with fetal calf serum (FCS,
30%), 1% BSA, 0.1 mM ß-mercaptoethanol, and with or
without Tan IIA (2 ug/ml), PXR inhibitor L-sulfora-
phane (L-SFN) (1 uM) [19]. U937 cells (1 × 103 cells/
mL) were seeded in triplicate and incubated for 3 days.
The colony was considered as a cluster of 10 or more
cells. Colonies were scored blindly.
Statistical analysis
All experiments were performed in triplicate. The
results were expressed as mean ± SD. Correlation ana-
lyses were performed using JMP software (version 6,
SAS, NC, USA).
Results
Cytotoxicity of Tan IIA on various leukemia cell lines
Previous studies show that Tan IIA’s effects are cell-spe-
cific. To identify a cell line sensitive to Tan IIA treat-
ment as the model system for further study, five cell
lines, namely, HL-60, MEG-01, MOLT-4, THP-1 and U-
937 cell lines, were treated with Tan IIA at 30 μg/mL
for 24 h. We observed that Tan IIA displayed different
cytotoxic activities on the five types of leukemia cells
(Figure 1). Compared with the control group (treated
with 0.1% DMSO), the viability rates of HL-60, MEG-
01, MOLT-4, THP-1 and U-937 cells were 40.0%, 62.5%,
45.6%, 89.5% and 10.3%, respectively. The corresponding
cytotoxicity of Tan IIA on U-937 cells was significantly
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higher than that of the other cell lines; thus, further stu-
dies were conducted on these cells.
Specific growth-inhibitory effects of Tan IIA on the U-937
cells
To determine if the effects of Tan IIA on U-937 were
specific, U-937 cells were treated with Tan IIA at differ-
ent concentrations of 1, 2, 3, 5 and 10 μg/mL for 12, 24,
36 and 48 h, respectively. As shown in Figure 2A, Tan
IIA at concentrations over 2 μg/mL induced apoptosis
when cultured with U-937 cells after 24-48 h. The per-
centage of cells that survived gradually decreased in a
time- and dose-dependent manner. The morphologies of
the apoptotic cells are shown in Figure 2B. Cellular
surface alterations of U-937 cells were clearly observed
after treatment with 3 μg/mL of Tan IIA for 24-36 h
under phase-contrast microscopy. As indicated by
arrows in Figure 2B, apoptotic cells exhibited rounding,
shrinkage and blebbing of the plasma membrane, all of
which are hallmarks of apoptosis.
Test of Tan IIA-induced apoptosis in U-937 cells using
Annexin V assay
To further confirm the apoptotic effects of Tan IIA on
U-937 cells, we measured the percentage of cells under-
going apoptosis after Tan IIA treatment using Annexin
V assay. As shown in Figure 3, the amount of apoptotic
cells gradually increased after treatments with Tan IIA
at 3 μg/mL for 12-24 h. Figure 3E indicates that treat-
ments with Tan IIA for 24 h significantly increased
apoptotic cell populations in R1 (annexin V positive, PI
negative, cells at the early phase of apoptosis), R2
(annexin V positive, PI positive, cells at the late phase of
apoptosis), as well as R1+R2 (annexin V positive, total
number of cells undergoing apoptosis).
Test of Tan IIA-induced apoptosis in U-937 cells using
Caspase 3 assay
We also measured the percentage of cells showing an
elevated activity of caspase-3 in U-937 cells after Tan
IIA treatment. Caspase 3 is a downstream effector pro-
tein of apoptosis and its elevated activity is indicative of
cells undergoing apoptosis. As shown in Figure 4, the
percentage of cells expressing caspase-3 in the control
and DMSO-treated samples are similar. However, the
Figure 2 Inhibitory effects of Tan IIA on the proliferation of U-937 cells. (A) The percentage of cells that survived gradually decreased in a
time- and dose-dependent manner after Tan IIA treatment. (B) Morphological changes of U-937 cells without (DMSO) and with Tan IIA
treatment. The U-937 cells were treated with Tan IIA and the morphology of cell apoptosis was examined by phase-contrast microscopy. The
magnification of the squared regions is shown to the right. Several cells undergoing apoptosis are indicated by arrows.
Figure 1 Inhibitory effects of Tan IIA on five leukemia cell
lines. After the cells were treated with 30 μg/mL of Tan IIA for 24
h, MTT assay was used to detect cell viability rate.
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samples that have been treated with Tan IIA for various
times had significantly higher percentages of cells
detected with caspase-3 activity. Our results confirmed
that Tan IIA induces apoptosis in U-937 cells.
Genome-wide expression profiling of U-937 cells treated
with Tan IIA
To identify the potential molecular targets of Tan IIA,
we employed Affymetrix GeneChip to identify genes
that are up- and down-regulated in Tan IIA-treated U-
937 cells. After preprocessing the raw data, the ratio of
the intensity for each probe from samples treated with
Tan IIA to that from untreated samples were calculated.
The ratio was further log transformed using base 2 to
generate the log2(fold change). All probe sets were then
ranked based on the log2 (fold change). Genes that had
log2 (fold change) greater than 1 or less than -1 after 12
h or 24 h of Tan IIA treatment were initially selected.
These include 366 significantly differentially expressed
genes (SDEGs) (Additional file 1, Table S2). From the
annotation, many of these genes were found belonging
to cell-cycle control, apoptosis pathways. Among the
genes related to the apoptosis pathway, chemokine
ligand 2 (CCL2, also named monocyte chemoattractant
protein-1, MCP-1) is the most significantly down-regu-
lated gene, whose expression has been down-regulated
to -3.06- and -3.64-fold in the log scale after 12 and 24
h treatment, respectively. This correspondeded to ~10-
fold down-regulation.
To include more genes for apoptosis-related pathways
analysis we loosened the selection criteria and the genes
that were differentially expressed with absolute fold
change > 1.5 were further analyzed. Genes involved in
apoptosis, NF-B cascade and cell proliferation path-
ways are showed in Additional file 1, Table S3.
Genome-wide expression profiling of five untreated cell
lines
To identify genes that are related to U937’s sensitivities
to Tan IIA, we carried out expression profiling using
U133 human GeneChips on five untreated cell lines
described in Figure 1. After preprocessing the data, we
Figure 3 Apoptotic effects of Tan IIA on U-937 cells analyzed by Annexin V assay. Cells were treated with Tan IIA at 3 μg/mL and cultured
for various time. The cells were stained with Annexin V-FITC and Propidium Iodide (PI) and subjected to flow cytometry analyses. Dot plots of
control samples (A), DMSO-treated samples (B), samples treated with Tan IIA for 12 h (C), and samples treated with Tan IIA for 24 h (D) are
shown. (E) Depicts the quantification and statistical analyses of the treatment effects. Percentages of early (R1, FITC+ and PI-), late (R2, FITC+ and
PI+) and total (R1+R2, FITC+) apoptotic cells are shown. Experiments were repeated three times. Bars denote the standard error of the mean.
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performed the correlation analyses, in which the correla-
tion between the Tan IIA’s toxicity (represented by the
percentage of cells that survived after treatment with
Tan IIA at 30 μg/mL for 24 h) and the expression levels
across the five different cell lines for each probe set was
calculated. All probe sets were then sorted based on the
correlation coefficient. The correlations for the probe
sets significantly differentially expressed after Tan IIA
treatment are shown in Additional file 1, Table S4.
Compared with the previous experiments, CCL2 has a
Figure 4 Apoptotic effects of Tan IIA on U-937 cells analyzed by Caspase 3 assay. U-937 cells are treated as described above, stained with
Caspase 3-PE (FL-2) and subjected to flow cytometry analysis. Panels (A)-(D) show the histograms of control samples, DMSO-treated samples and
Tan IIA treated samples for 12 h or 24 h respectively. Experiments were repeated three times. Bars denote the standard error of the mean.
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correlation coefficient of -0.788 and another gene,
BCL2A1 has a correlation coefficient of -0.85. It should
be pointed out that due to the diverse genetic back-
ground of the cell lines, different sets of genes might
respond to Tan IIA treatment in these different cell
lines. However, we think these results, when combined
with those of other experiments, could still provide use-
ful information for genes whose expression level
responding to Tan IIA treatment.
Validation of GeneChip data by RT-qPCR analysis
To validate the GeneChip results, we selected 30 genes
that are involved in apoptosis-related pathways from
Additional file 1, Table S3 for RT-qPCR analysis. The
results are shown in Figure 5. As shown, three genes are
up-regulated > 1 in the log2 (fold change) scale after
Tan IIA treatment. And eight genes including CCL2,
BIRC5 (Survivin), BCL2, IL8, HSPA1A, MYC, PRKCZ
and SERPINB2 are down-regulated for more than one
fold change (-1 in the log2 (fold change) scale). In total,
we found that the directions of expression change for
80% of genes are consistent between GeneChip data and
RT-qPCR data.
RT-qPCR and ELISA analyses of CCL2 mRNA and protein
expression in U-937 cells treated with Tan IIA
CCL2 that plays a role in the apoptosis pathway was one
of the most significantly down-regulated genes; hence,
we decided to study CCL2 further. To confirm the
down-regulation of CCL2 expression in U-937, we
examined the expression patterns of CCL2 in U-937
cells treated with Tan IIA using RT-qPCR and ELISA
analyses. Our results showed that the mRNA levels of
CCL2 in treated cells were lower than those of the con-
trol (Figure 6A). The CCL2 expression level clearly
decreased after treatment with Tan IIA treatments for 2
h and reached the lowest level at 12 h, more than 10-
fold down-regulation. The results of ELISA also con-
firmed the down-regulation of CCL2 expression in the
treated cells at the protein level. We found that the
CCL2 concentration in treated cells gradually decreased
from 2273.33 pg/mL in the untreated cells to 1450 and
245 pg/mL after Tan IIA treatments at 1.0 and 18.0 μg/
mL for 12 h, respectively (Figure 6B). These results indi-
cate that Tan IIA significantly inhibit the expression of
CCL2 at mRNA and protein levels.
Antagonizing Tan IIA activity by PXR inhibitor L-SFN
Previous study suggests that one of Tan IIA’s direct tar-
gets is PXR [20]. To test if Tan IIA indeed acts through
PXR, we tested the colony forming efficiency in the pre-
sence and absence of Tan IIA and L-SFN (Figure 7). As
shown, compared with that of the control (47 ± 1.83),
Tan IIA reduced the number of colony forming units to
23 ± 2.1. L-SFN alone had little effects on the number
of CFUs (44.5 ± 3.1). However, addition of L-SFN
Figure 5 Tan IIA induces mRNA expression of genes involved in apoptosis-related pathways. Graphic representation of mRNA expression
for the indicated genes at 24 h after Tan IIA treatment (3 μg/mL), as measured using RT-qPCR or Affymetrix GeneChip. Bars denote the standard
error of the mean. Genes that have log2 (fold change) greater than 1 or less than -1 are indicated with arrows.
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significantly mitigated the effect of Tan IIA, reducing
colony forming units to 36.5 ± 1.3. The results sug-
gested that L-SFN antagonizes Tan IIA’s effect.
Discussion
In the present study, we aimed to systematically investi-
gate the molecular mechanisms underlying the growth
inhibitory effect of Tan IIA on leukemia cells. We found
that Tan IIA displays significant cytotoxicity on U-937
cells compared with several other cell lines. The inhibi-
tory effects are time- and dose- dependent. The change
in cellular morphological features and the results of
annexin V/caspase 3 analyses suggest that the induction
of apoptosis is responsible for Tan IIA-induced U-937
cell death. Through genome-wide expression profiling,
we found that the most significantly regulated gene in
response to Tan IIA treatment is chemokine CCL2.
These raised two questions: whether or not down-regu-
lation of CCL2 is responsible for cellular apoptosis and
how Tan IIA leads to the down-regulation of CCL2.
Chemokines are small heparin-binding proteins that
interact with their receptors, regulating many pathophy-
siological responses in hematological malignancy and
inflammatory diseases [21,22]. CCL2 belongs to the CC
chemokine family and is produced by a variety of cell
types, including monotype, macrophages and many
others. As a potent chemoattractant, CCL2 and its
receptor, CCR2, play vital roles in regulating the migra-
tion and infiltration of monocyte, T lymphocytes and
natural killer cells [23]. Recent studies have described
the tumor-promoting roles of CCL2/MCP-1 in eosino-
philic leukemia EoL-1 cells [22] and breast cancel cells
[24-27]. Two molecular mechanisms have also been pro-
posed for CCL2’s effects. One is that CCL2 negatively
regulates AMP-Activated Protein Kinase to sustain
mTOR Complex-1 activation, surviving expression and
cell survival in human prostate cancer PC3 cells [27].
The other is that CCL2 activates Gi/Go protein/PLC/
PKCδ/ p38 MAPK cascade and PKCδ acts as an anti-
apoptotic molecule by regulation of the caspase 3 and
caspase 9 [24]. Consequently, it is conceivable that the
disruption of CCL2 signaling pathways could promote
apoptosis and stunt growth of U-937 cells.
During the course of our study, another report
showed that Tan IIA is an agonist of pregnane × recep-
tor (PXR, NR1l2) [20]. We then tested the effect of a
PXR antagonist, L-SFN on Tan IIA-treated cells using
colony forming unit assay and found that L-SFN signifi-
cantly mitigate Tan IIA’s growth-inhibition effect. Pre-
vious studies have also showed that nuclear
Figure 6 Dose dependent regulation of CCL2 expression by Tan IIA. (A) Regulation of CCL2 mRNA expression analyzed by RT-qPCR
experiments. U-937 cells were treated as described in methods. Transcript levels were measured by RT-qPCR using BAL as an internal reference.
Bars denote the standard error of the mean. All experiments were repeated three times. (B) Regulation of CCL2 protein expression determined
by ELISA. U-937 cells were treated as described in methods. Experiments were repeated three times. Bars denote the standard error of the mean.
Figure 7 PXR inhibitor L-SFN alleviates Tan IIA’s inhibitory
effect of the formation of Colony Forming Units (CFU).
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transcription factor- B (NF-B) regulates the transcrip-
tion of many inflammatory mediators, including CCL2.
Lack of NF-B activity significantly reduced injury-
induced CCL2 expression in astrocytes [28]. Sequence
analyses have found NF-B binding sites on the
upstream of CCL2 coding sequences [29]. Furthermore,
the interaction of PXR and NF-B has been described
[30]. PXR and NF-B compete for the RXR to form het-
erodimer which are required for the transcription of
their target genes [31].
Integrating above information with our experimental
results, we proposed a model explaining Tan IIA-
induced, CCL2-mediated apoptosis of U-937 cells (Fig-
ure 8). Based on this model, CCL2 is highly expressed
in U-937 cells compared with other cells and is critical
for the U-937 cell’s survival, possibly through the nega-
tive regulation of the AMP-Activated Protein Kinase
pathway and positive regulation of the Gi/Go protein/
PLC/PKCδ/p38 MAPK pathway. The high level expres-
sion of CCL2 is maintained by the hyperactivation of
NF-B. Tan IIA is an agonist of PXR, activation of PXR
disrupts the high level expression of CCL2 maintained
by NF-B hyperactivation. This leads to the collapse of
CCL2’s high level expression and consequently pro-
motes the apoptosis of U-937 cells. Additional experi-
ments are needed to further test this model.
Conclusions
In the current study, we showed that Tan IIA, a diter-
pene quinone extracted from the root of Salvia miltior-
rhiza, has significant growth inhibition effect on U-937
cells in vitro through apoptosis induction. Using gen-
ome-wide gene expression profiling, we identified hun-
dreds of genes that are significantly up-and down-
regulated after Tan IIA treatment. One likely mechan-
ism is that CCL2 is significantly over-expressed in U-
937 cells and might play an important role in the survi-
val and proliferation of U-937 cells. Tan IIA activates
PXR, which inhibits NF-B activity, leading to the sig-
nificantly down-regulation of CCL2 expression by
approximately 10-fold, resulting in the apoptosis of U-
937 cells.
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Additional file 1: Table S1. List of primers for RT-qPCR. Table S2. List of
significantly regulated genes after Tan IIA treatment in U-973 cells. Table
S3. List of differentially expressed genes (> 1.5-fold changes) identified
from Affymetrix GeneChip experiments that are involved in apoptosis,
NF-B signaling cascade and cell proliferation pathways. Table S4. List of
correlations between expression profiles of each gene across the five cell
lines and the cell lines’ Tan IIA sensitivities to Tan IIA’s treatment.
Acknowledgements
The authors acknowledge the grant support from HongKong Research
Council (HKU7526/06 M, C Liu), startup grant for “Xiehe Scholar” from
Chinese Academy of Medical Science (PUMC 2569, C Liu), the Children
Cancer Foundation of Hong Kong (M Yang and CK Li), Seed Funding
Program of Nanfang Hospital (M Yang), Nanfang Hospital President
Foundation (2011A001, M Yang ) and Nanfang Hospital President
Foundation (2012C017, FQ Wu).
Author details
1Institute of Medicinal Plant Development, Chinese Academy of Medical
Science, 151 MaLianWa North Road, Beijing, 100193, P.R.China. 2Department
of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou,
Guangdong 510515, P.R. China. 3Institute of Hematology, Medical College,
Jinan University, Guangzhou 510632, P.R.China. 4LKS Faculty of Medicine, The
University of Hong Kong, Hong Kong, P.R. China.
Authors’ contributions
CL and MY designed the current study. CL analyzed the GeneChip data.
LJW performed the cellular toxicity and apoptosis assays, and carried out the
QPCR and ELISA experiments. JQL drafted the manuscript. YQC critically
reviewed the manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 27 May 2011 Accepted: 16 January 2012
Published: 16 January 2012
References
1. Stass SAS, Harold R, Rock , William R: Handbook of hematologic
pathology. New York: Marcel Dekker; 2000.
2. Wargovich MJ, Woods C, Hollis DM, Zander ME: Herbals, cancer
prevention and health. J Nutr 2001, 131(11 Suppl):3034S-3036S.
3. Boon H, Wong J: Botanical medicine and cancer: a review of the safety
and efficacy. Expert Opin Pharmacother 2004, 5(12):2485-2501.
Figure 8 A proposed model for CCL2-mediated, Tan IIA-
induced apoptosis in U-937 cells.
Liu et al. BMC Complementary and Alternative Medicine 2012, 12:5
http://www.biomedcentral.com/1472-6882/12/5
Page 9 of 10
4. Sung HJ, Choi SM, Yoon Y, An KS: Tanshinone IIA, an ingredient of Salvia
miltiorrhiza BUNGE, induces apoptosis in human leukemia cell lines
through the activation of caspase-3. Exp Mol Med 1999, 31(4):174-178.
5. Liu JJ, Zhang Y, Lin DJ, Xiao RZ: Tanshinone IIA inhibits leukemia THP-1
cell growth by induction of apoptosis. Oncol Rep 2009, 21(4):1075-1081.
6. Zhang K, Li J, Meng W, Xing H, Yang Y: C/EBPbeta and CHOP participate
in Tanshinone IIA-induced differentiation and apoptosis of acute
promyelocytic leukemia cells in vitro. Int J Hematol 2010, 92(4):571-578.
7. Yuan SL, Wei YQ, Wang XJ, Xiao F, Li SF, Zhang J: Growth inhibition and
apoptosis induction of tanshinone II-A on human hepatocellular
carcinoma cells. World J Gastroenterol 2004, 10(14):2024-2028.
8. Su CC, Lin YH: Tanshinone IIA inhibits human breast cancer cells through
increased Bax to Bcl-xL ratios. Int J Mol Med 2008, 22(3):357-361.
9. Lu Q, Zhang P, Zhang X, Chen J: Experimental study of the anti-cancer
mechanism of tanshinone IIA against human breast cancer. Int J Mol
Med 2009, 24(6):773-780.
10. Zhou L, Chan WK, Xu N, Xiao K, Luo H, Luo KQ, Chang DC: Tanshinone IIA,
an isolated compound from Salvia miltiorrhiza Bunge, induces apoptosis
in HeLa cells through mitotic arrest. Life Sci 2008, 83(11-12):394-403.
11. Pan TL, Hung YC, Wang PW, Chen ST, Hsu TK, Sintupisut N, Cheng CS,
Lyu PC: Functional proteomic and structural insights into molecular
targets related to the growth inhibitory effect of tanshinone IIA on HeLa
cells. Proteomics 2010, 10(5):914-929.
12. Chiu TL, Su CC: Tanshinone IIA induces apoptosis in human lung cancer
A549 cells through the induction of reactive oxygen species and
decreasing the mitochondrial membrane potential. Int J Mol Med 2010,
25(2):231-236.
13. van de Loosdrecht AA, Beelen RH, Ossenkoppele GJ, Broekhoven MG,
Langenhuijsen MM: A tetrazolium-based colorimetric MTT assay to
quantitate human monocyte mediated cytotoxicity against leukemic
cells from cell lines and patients with acute myeloid leukemia. J
Immunol Methods 1994, 174(1-2):311-320.
14. Liu C, Li J, Meng FY, Liang SX, Deng R, Li CK, Pong NH, Lau CP, Cheng SW,
Ye JY, et al: Polysaccharides from the root of Angelica sinensis promotes
hematopoiesis and thrombopoiesis through the PI3K/AKT pathway. BMC
Complement Altern Med 2010, 10:79.
15. Li C, Wong WH: DNA-chip analyzer (dChip). New York: Springer; 2003.
16. Li C, Hung Wong W: Model-based analysis of oligonucleotide arrays:
model validation, design issues and standard error application. Genome
Biol 2001, 2(8):RESEARCH0032.
17. Li C, Wong WH: Model-based analysis of oligonucleotide arrays:
expression index computation and outlier detection. Proc Natl Acad Sci
USA 2001, 98(1):31-36.
18. Doniger SW, Salomonis N, Dahlquist KD, Vranizan K, Lawlor SC, Conklin BR:
MAPPFinder: using Gene Ontology and GenMAPP to create a global
gene-expression profile from microarray data. Genome Biol 2003, 4(1):R7.
19. Zhou C, Poulton EJ, Grun F, Bammler TK, Blumberg B, Thummel KE,
Eaton DL: The dietary isothiocyanate sulforaphane is an antagonist of
the human steroid and xenobiotic nuclear receptor. Mol Pharmacol 2007,
71(1):220-229.
20. Yu C, Ye S, Sun H, Liu Y, Gao L, Shen C, Chen S, Zeng S: PXR-mediated
transcriptional activation of CYP3A4 by cryptotanshinone and
tanshinone IIA. Chem Biol Interact 2009, 177(1):58-64.
21. Broxmeyer HE: Regulation of hematopoiesis by chemokine family
members. Int J Hematol 2001, 74(1):9-17.
22. Murdoch C, Finn A: Chemokine receptors and their role in inflammation
and infectious diseases. Blood 2000, 95(10):3032-3043.
23. Deshmane SL, Kremlev S, Amini S, Sawaya BE: Monocyte chemoattractant
protein-1 (MCP-1): an overview. J Interferon Cytokine Res 2009,
29(6):313-326.
24. Lee JS, Yang EJ, Kim IS: The roles of MCP-1 and protein kinase C delta
activation in human eosinophilic leukemia EoL-1 cells. Cytokine 2009,
48(3):186-195.
25. Soria G, Yaal-Hahoshen N, Azenshtein E, Shina S, Leider-Trejo L, Ryvo L,
Cohen-Hillel E, Shtabsky A, Ehrlich M, Meshel T, et al: Concomitant
expression of the chemokines RANTES and MCP-1 in human breast
cancer: a basis for tumor-promoting interactions. Cytokine 2008,
44(1):191-200.
26. Soria G, Ben-Baruch A: The inflammatory chemokines CCL2 and CCL5 in
breast cancer. Cancer Lett 2008, 267(2):271-285.
27. Roca H, Varsos ZS, Pienta KJ: CCL2 is a negative regulator of AMP-
activated protein kinase to sustain mTOR complex-1 activation, survivin
expression, and cell survival in human prostate cancer PC3 cells.
Neoplasia 2009, 11(12):1309-1317.
28. Khorooshi R, Babcock AA, Owens T: NF-kappaB-driven STAT2 and CCL2
expression in astrocytes in response to brain injury. J Immunol 2008,
181(10):7284-7291.
29. Ueda A, Okuda K, Ohno S, Shirai A, Igarashi T, Matsunaga K, Fukushima J,
Kawamoto S, Ishigatsubo Y, Okubo T: NF-kappa B and Sp1 regulate
transcription of the human monocyte chemoattractant protein-1 gene. J
Immunol 1994, 153(5):2052-2063.
30. Zhou C, Tabb MM, Nelson EL, Grun F, Verma S, Sadatrafiei A, Lin M,
Mallick S, Forman BM, Thummel KE, et al: Mutual repression between
steroid and xenobiotic receptor and NF-kappaB signaling pathways links
xenobiotic metabolism and inflammation. J Clin Invest 2006,
116(8):2280-2289.
31. Gu X, Ke S, Liu D, Sheng T, Thomas PE, Rabson AB, Gallo MA, Xie W, Tian Y:
Role of NF-kappaB in regulation of PXR-mediated gene expression: a
mechanism for the suppression of cytochrome P-450 3A4 by
proinflammatory agents. J Biol Chem 2006, 281(26):17882-17889.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1472-6882/12/5/prepub
doi:10.1186/1472-6882-12-5
Cite this article as: Liu et al.: Analysis of tanshinone IIA induced cellular
apoptosis in leukemia cells by genome-wide expression profiling. BMC
Complementary and Alternative Medicine 2012 12:5.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Liu et al. BMC Complementary and Alternative Medicine 2012, 12:5
http://www.biomedcentral.com/1472-6882/12/5
Page 10 of 10
